HEADER STRUCTURAL PROTEIN 29-MAR-06 2DIA TITLE SOLUTION STRUCTURE OF THE 10TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B COMPND MOL_ID: 1; COMPND 2 MOLECULE: FILAMIN-B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FILAMIN DOMAIN; COMPND 5 SYNONYM: FLN-B, BETA-FILAMIN, ACTIN-BINDING-LIKE PROTEIN, THYROID COMPND 6 AUTOANTIGEN, TRUNCATED ACTIN-BINDING PROTEIN, TRUNCATED ABP, ABP-280 COMPND 7 HOMOLOG, ABP-278, FILAMIN 3, FILAMIN HOMOLOG 1, FH1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLNB; SOURCE 6 EXPRESSION_SYSTEM: CELL FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: P051205-11; SOURCE 9 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS BETA-SANDWICH, IMMUNOGLOBULIN-LIKE FOLD, FILAMIN DOMAIN, STRUCTURAL KEYWDS 2 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 3 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.TOMIZAWA,S.KOSHIBA,S.WATANABE,T.HARADA,T.KIGAWA,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2DIA 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DIA 1 VERSN REVDAT 1 29-SEP-06 2DIA 0 JRNL AUTH T.TOMIZAWA,S.KOSHIBA,S.WATANABE,T.HARADA,T.KIGAWA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE 10TH FILAMIN DOMAIN FROM HUMAN JRNL TITL 2 FILAMIN-B JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DIA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000025446. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.11MM FILAMIN DOMAIN U-15N,13C; REMARK 210 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20030801, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9742, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY, STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 10 119.15 -172.34 REMARK 500 1 SER A 37 -67.21 -108.88 REMARK 500 1 PRO A 41 -166.88 -69.75 REMARK 500 1 PRO A 92 3.63 -69.79 REMARK 500 1 ALA A 103 38.67 -96.02 REMARK 500 2 ASP A 10 118.74 -170.67 REMARK 500 2 VAL A 26 109.56 -52.30 REMARK 500 2 SER A 37 -70.36 -95.22 REMARK 500 2 PRO A 41 -163.81 -69.76 REMARK 500 2 ASP A 65 39.52 -84.19 REMARK 500 2 PRO A 92 4.43 -69.71 REMARK 500 2 ALA A 103 40.08 -84.47 REMARK 500 3 ASP A 10 115.30 -162.25 REMARK 500 3 SER A 37 -65.38 -104.66 REMARK 500 3 PRO A 41 -167.57 -69.83 REMARK 500 3 ASN A 62 102.78 -53.37 REMARK 500 3 LYS A 64 48.23 -76.36 REMARK 500 3 PRO A 92 3.59 -69.82 REMARK 500 3 ALA A 103 46.37 -93.18 REMARK 500 3 SER A 107 166.15 -42.90 REMARK 500 3 SER A 111 126.01 -34.45 REMARK 500 3 SER A 112 123.03 -172.44 REMARK 500 4 ASP A 10 117.50 -168.07 REMARK 500 4 SER A 37 -69.40 -124.51 REMARK 500 4 PRO A 41 -170.13 -69.74 REMARK 500 4 LYS A 64 41.56 -85.25 REMARK 500 4 PRO A 92 3.07 -69.78 REMARK 500 4 ALA A 103 35.91 -99.85 REMARK 500 4 SER A 111 98.91 -60.04 REMARK 500 5 SER A 3 49.38 -84.15 REMARK 500 5 ASP A 10 118.90 -168.04 REMARK 500 5 GLU A 28 -178.63 -61.48 REMARK 500 5 PRO A 41 -163.63 -69.75 REMARK 500 5 SER A 52 31.63 -88.63 REMARK 500 5 PRO A 92 4.89 -69.71 REMARK 500 5 ALA A 103 44.69 -83.97 REMARK 500 5 PRO A 110 -172.24 -69.73 REMARK 500 5 SER A 111 96.64 -63.72 REMARK 500 5 SER A 112 47.51 39.27 REMARK 500 6 ASP A 10 117.25 -164.50 REMARK 500 6 SER A 37 -66.23 -124.59 REMARK 500 6 PRO A 41 -171.09 -69.79 REMARK 500 6 LYS A 64 33.30 -94.75 REMARK 500 6 PRO A 92 3.67 -69.72 REMARK 500 6 ALA A 103 46.69 -88.19 REMARK 500 6 SER A 112 99.90 -62.56 REMARK 500 7 ASP A 10 117.67 -166.20 REMARK 500 7 SER A 37 -62.08 -102.60 REMARK 500 7 PRO A 41 -164.62 -69.71 REMARK 500 7 PRO A 92 3.96 -69.78 REMARK 500 REMARK 500 THIS ENTRY HAS 139 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK003002600.2 RELATED DB: TARGETDB DBREF 2DIA A 8 107 UNP O75369 FLNB_HUMAN 1016 1035 SEQADV 2DIA GLY A 1 UNP O75369 CLONING ARTIFACT SEQADV 2DIA SER A 2 UNP O75369 CLONING ARTIFACT SEQADV 2DIA SER A 3 UNP O75369 CLONING ARTIFACT SEQADV 2DIA GLY A 4 UNP O75369 CLONING ARTIFACT SEQADV 2DIA SER A 5 UNP O75369 CLONING ARTIFACT SEQADV 2DIA SER A 6 UNP O75369 CLONING ARTIFACT SEQADV 2DIA GLY A 7 UNP O75369 CLONING ARTIFACT SEQADV 2DIA ASP A 35 UNP O75369 ASN 1157 SEE REMARK 999 SEQADV 2DIA SER A 108 UNP O75369 CLONING ARTIFACT SEQADV 2DIA GLY A 109 UNP O75369 CLONING ARTIFACT SEQADV 2DIA PRO A 110 UNP O75369 CLONING ARTIFACT SEQADV 2DIA SER A 111 UNP O75369 CLONING ARTIFACT SEQADV 2DIA SER A 112 UNP O75369 CLONING ARTIFACT SEQADV 2DIA GLY A 113 UNP O75369 CLONING ARTIFACT SEQRES 1 A 113 GLY SER SER GLY SER SER GLY PRO PHE ASP PRO SER LYS SEQRES 2 A 113 VAL VAL ALA SER GLY PRO GLY LEU GLU HIS GLY LYS VAL SEQRES 3 A 113 GLY GLU ALA GLY LEU LEU SER VAL ASP CYS SER GLU ALA SEQRES 4 A 113 GLY PRO GLY ALA LEU GLY LEU GLU ALA VAL SER ASP SER SEQRES 5 A 113 GLY THR LYS ALA GLU VAL SER ILE GLN ASN ASN LYS ASP SEQRES 6 A 113 GLY THR TYR ALA VAL THR TYR VAL PRO LEU THR ALA GLY SEQRES 7 A 113 MET TYR THR LEU THR MET LYS TYR GLY GLY GLU LEU VAL SEQRES 8 A 113 PRO HIS PHE PRO ALA ARG VAL LYS VAL GLU PRO ALA VAL SEQRES 9 A 113 ASP THR SER SER GLY PRO SER SER GLY HELIX 1 1 ASP A 10 SER A 12 5 3 HELIX 2 2 GLY A 18 GLU A 22 5 5 SHEET 1 A 4 VAL A 14 SER A 17 0 SHEET 2 A 4 LEU A 32 CYS A 36 -1 O ASP A 35 N VAL A 15 SHEET 3 A 4 THR A 67 VAL A 73 -1 O TYR A 68 N VAL A 34 SHEET 4 A 4 GLU A 57 ASN A 62 -1 N GLN A 61 O ALA A 69 SHEET 1 B 5 GLY A 24 LYS A 25 0 SHEET 2 B 5 ALA A 96 GLU A 101 1 O GLU A 101 N GLY A 24 SHEET 3 B 5 GLY A 78 TYR A 86 -1 N TYR A 80 O VAL A 98 SHEET 4 B 5 LEU A 44 SER A 50 -1 N GLY A 45 O LYS A 85 SHEET 5 B 5 THR A 54 LYS A 55 -1 O THR A 54 N SER A 50 SHEET 1 C 4 GLY A 24 LYS A 25 0 SHEET 2 C 4 ALA A 96 GLU A 101 1 O GLU A 101 N GLY A 24 SHEET 3 C 4 GLY A 78 TYR A 86 -1 N TYR A 80 O VAL A 98 SHEET 4 C 4 GLU A 89 LEU A 90 -1 O GLU A 89 N TYR A 86 CISPEP 1 PHE A 94 PRO A 95 1 -0.02 CISPEP 2 PHE A 94 PRO A 95 2 -0.01 CISPEP 3 PHE A 94 PRO A 95 3 -0.02 CISPEP 4 PHE A 94 PRO A 95 4 0.04 CISPEP 5 PHE A 94 PRO A 95 5 0.02 CISPEP 6 PHE A 94 PRO A 95 6 0.00 CISPEP 7 PHE A 94 PRO A 95 7 0.03 CISPEP 8 PHE A 94 PRO A 95 8 0.00 CISPEP 9 PHE A 94 PRO A 95 9 0.02 CISPEP 10 PHE A 94 PRO A 95 10 0.02 CISPEP 11 PHE A 94 PRO A 95 11 -0.10 CISPEP 12 PHE A 94 PRO A 95 12 -0.01 CISPEP 13 PHE A 94 PRO A 95 13 0.01 CISPEP 14 PHE A 94 PRO A 95 14 -0.04 CISPEP 15 PHE A 94 PRO A 95 15 0.06 CISPEP 16 PHE A 94 PRO A 95 16 0.00 CISPEP 17 PHE A 94 PRO A 95 17 0.05 CISPEP 18 PHE A 94 PRO A 95 18 0.02 CISPEP 19 PHE A 94 PRO A 95 19 -0.01 CISPEP 20 PHE A 94 PRO A 95 20 0.06 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1